Paris-based MedTech TISSIUM secures a €60M financing package, including EIB backing, to commercialize its FDA-cleared light-activated polymer in the US.

Paris-based MedTech TISSIUM secures a €60M financing package, including EIB backing, to commercialize its FDA-cleared light-activated polymer in the US.

The funds will be used to roll out its tech in the US.